# Serum NGAL Levels in Hemodialysis (HD) Patients; Relation to Iron Status, HD and Intravenous (IV) Iron Administration

> **NCT00560976** · NA · UNKNOWN · sponsor: **Soroka University Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Renal Failure Chronic Requiring Hemodialysis

## Interventions

- **DRUG:** Iron Saccharate (Venofer)

## Key facts

- **NCT ID:** NCT00560976
- **Lead sponsor:** Soroka University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-12
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2013-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00560976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00560976, "Serum NGAL Levels in Hemodialysis (HD) Patients; Relation to Iron Status, HD and Intravenous (IV) Iron Administration". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00560976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*